Researcher

Qi Wu

Obstetrical Department, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

SEP 3, 2026 · REVIEW

Sodium-glucose cotransporter-2 inhibitors and gastrointestinal neoplasm risk in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials

Clinical and Experimental Medicine

A rigorous meta-analysis of 48 RCTs with 48,765 participants showing no significant association between SGLT2 inhibitors and gastrointestinal neoplasm risk, with consistent null findings across multiple site-specific and subgroup analyses, though long-term safety remains incompletely characterized.

Strong EvidenceJiajie Xie Qi Wu Metabolism, Diabetes, and Cancer

Reported

Overall GI neoplasm risk, odds ra…1.10

Overall GI neoplasm risk, 95% CI0.84–1.44

Overall GI neoplasm risk, p-value0.46

JUL 26, 2026 · JOURNAL ARTICLE

Gestational cardiovascular health and adverse pregnancy outcomes: a prospective cohort study in China.

Annals of Medicine

Prospective cohort study in a large Chinese population demonstrates significant associations between gestational cardiovascular health metrics and reduced adverse pregnancy outcomes, with clear dose-response relationships, but lacks a comparator intervention and cannot establish causation.

PromisingQi Wu Cardiovascular Diseases Yihui Wu

Reported

Sample size2775

High CVH prevalence36.07%

Moderate CVH prevalence36.11%